Polar Capital Healthcare Opportunities breaches 10% exposure limit after Danish pharma firm soars

Zealand Pharma A/S

Eve Maddock-Jones
clock • 1 min read

The Polar Capital Healthcare Opportunities fund has breached the 10% holding limit for UCITS funds, as its top holding swelled to more than 12% of the vehicle thanks to a rally in weight loss investments.

The fund's exposure to Danish pharmaceutical firm Zealand Pharma A/S hit 12.1%, according to its February factsheet, surpassing the 10% limit imposed on UCITS vehicles. Four Graphs explaining silver Zealand Pharma is involved in the production and design of diabetes and obesity medications, a corner of the healthcare market which has seen a huge surge in investment in the wake of Novo Nordisk's Ozempic medication becoming a cult product for weight loss. The company's shares had historically traded at around 200 DKK (£22.92) per share, but last month it experienc...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Funds

Willis Towers Watson eyes private equity LTAF launch

Willis Towers Watson eyes private equity LTAF launch

Available to individual professional investors

Cristian Angeloni
clock 15 April 2024 • 1 min read
Robeco renames three multi-asset funds in bid to enhance sustainability focus

Robeco renames three multi-asset funds in bid to enhance sustainability focus

Now capital growth funds

clock 11 April 2024 • 1 min read
Morningstar places raft of Blackrock bond funds under review after Krautzberger exit

Morningstar places raft of Blackrock bond funds under review after Krautzberger exit

‘Evaluating upcoming changes’

clock 11 April 2024 • 1 min read
Trustpilot